Molecular Mechanisms of Cystic Fibrosis - How Mutations Lead to Misfunction and Guide Therapy

Overview

Journal Biosci Rep

Specialty Cell Biology

Date 2022 Jun 16

PMID 35707985

Authors

Carlos M Farinha

Isabelle Callebaut

Affiliations

Soon will be listed here.

Abstract

Cystic fibrosis, the most common autosomal recessive disorder in Caucasians, is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which encodes a cAMP-activated chloride and bicarbonate channel that regulates ion and water transport in secretory epithelia. Although all mutations lead to the lack or reduction in channel function, the mechanisms through which this occurs are diverse - ranging from lack of full-length mRNA, reduced mRNA levels, impaired folding and trafficking, targeting to degradation, decreased gating or conductance, and reduced protein levels to decreased half-life at the plasma membrane. Here, we review the different molecular mechanisms that cause cystic fibrosis and detail how these differences identify theratypes that can inform the use of directed therapies aiming at correcting the basic defect. In summary, we travel through CFTR life cycle from the gene to function, identifying what can go wrong and what can be targeted in terms of the different types of therapeutic approaches.

Citing Articles

Human Induced Lung Organoids: A Promising Tool for Cystic Fibrosis Drug Screening.

Demchenko A, Balyasin M, Nazarova A, Grigorieva O, Panchuk I, Kondrateva E Int J Mol Sci. 2025; 26(2).

PMID: 39859153 PMC: 11764749. DOI: 10.3390/ijms26020437.

Exploring Therapeutic Strategies for Pediatric Cystic Fibrosis: An In-Depth Comparative Review.

Lakhani A, Clementina R, Siddiqua Z, Shroff S, Bhavanam S, Pandya M Cureus. 2024; 16(10):e71913.

PMID: 39564025 PMC: 11576056. DOI: 10.7759/cureus.71913.

Palmitoylation regulates norepinephrine transporter uptake, surface localization, and total expression with pathogenic implications in postural orthostatic tachycardia syndrome.

Brown C, Shetty M, Foster J J Neurochem. 2024; 169(2):e16241.

PMID: 39395208 PMC: 11808474. DOI: 10.1111/jnc.16241.

New drugs, new challenges in cystic fibrosis care.

Fajac I, Burgel P, Martin C Eur Respir Rev. 2024; 33(173).

PMID: 39322262 PMC: 11423132. DOI: 10.1183/16000617.0045-2024.

Lipoxygenases at the Intersection of Infection and Carcinogenesis.

Amoah A, Pestov N, Korneenko T, Prokhorenko I, Kurakin G, Barlev N Int J Mol Sci. 2024; 25(7).

PMID: 38612771 PMC: 11011848. DOI: 10.3390/ijms25073961.

References

Smith D, Nuthall H, Majetti M, Harris A . Multiple potential intragenic regulatory elements in the CFTR gene. Genomics. 2000; 64(1):90-6. DOI: 10.1006/geno.1999.6086. View

Hermann T . Aminoglycoside antibiotics: old drugs and new therapeutic approaches. Cell Mol Life Sci. 2007; 64(14):1841-52. PMC: 11136281. DOI: 10.1007/s00018-007-7034-x. View

Liu F, Zhang Z, Csanady L, Gadsby D, Chen J . Molecular Structure of the Human CFTR Ion Channel. Cell. 2017; 169(1):85-95.e8. DOI: 10.1016/j.cell.2017.02.024. View

Fu J, Ji H, Naren A, Kirk K . A cluster of negative charges at the amino terminal tail of CFTR regulates ATP-dependent channel gating. J Physiol. 2001; 536(Pt 2):459-70. PMC: 2278861. DOI: 10.1111/j.1469-7793.2001.0459c.xd. View

Bozoky Z, Krzeminski M, Muhandiram R, Birtley J, Al-Zahrani A, Thomas P . Regulatory R region of the CFTR chloride channel is a dynamic integrator of phospho-dependent intra- and intermolecular interactions. Proc Natl Acad Sci U S A. 2013; 110(47):E4427-36. PMC: 3839774. DOI: 10.1073/pnas.1315104110. View

Amaral M, Balch W . Hallmarks of therapeutic management of the cystic fibrosis functional landscape. J Cyst Fibros. 2015; 14(6):687-99. PMC: 4644672. DOI: 10.1016/j.jcf.2015.09.006. View

Somayaji R, Ramos K, Kapnadak S, Aitken M, Goss C . Common clinical features of CF (respiratory disease and exocrine pancreatic insufficiency). Presse Med. 2017; 46(6 Pt 2):e109-e124. DOI: 10.1016/j.lpm.2017.03.021. View

Cui L, Aleksandrov L, Chang X, Hou Y, He L, Hegedus T . Domain interdependence in the biosynthetic assembly of CFTR. J Mol Biol. 2006; 365(4):981-94. DOI: 10.1016/j.jmb.2006.10.086. View

Orro A, Uggeri M, Rusnati M, Urbinati C, Pedemonte N, Pesce E . In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library. Eur J Med Chem. 2021; 213:113186. DOI: 10.1016/j.ejmech.2021.113186. View

10.

Billet A, Mornon J, Jollivet M, Lehn P, Callebaut I, Becq F . CFTR: effect of ICL2 and ICL4 amino acids in close spatial proximity on the current properties of the channel. J Cyst Fibros. 2013; 12(6):737-45. DOI: 10.1016/j.jcf.2013.02.002. View

11.

Zhang Z, Liu F, Chen J . Conformational Changes of CFTR upon Phosphorylation and ATP Binding. Cell. 2017; 170(3):483-491.e8. DOI: 10.1016/j.cell.2017.06.041. View

12.

Kunzelmann K, Kathofer S, Greger R . Na+ and Cl- conductances in airway epithelial cells: increased Na+ conductance in cystic fibrosis. Pflugers Arch. 1995; 431(1):1-9. DOI: 10.1007/BF00374371. View

13.

Gosalia N, Neems D, Kerschner J, Kosak S, Harris A . Architectural proteins CTCF and cohesin have distinct roles in modulating the higher order structure and expression of the CFTR locus. Nucleic Acids Res. 2014; 42(15):9612-22. PMC: 4150766. DOI: 10.1093/nar/gku648. View

14.

Ramalho S, Silva I, Amaral M, Farinha C . Rare Trafficking CFTR Mutations Involve Distinct Cellular Retention Machineries and Require Different Rescuing Strategies. Int J Mol Sci. 2022; 23(1). PMC: 8744605. DOI: 10.3390/ijms23010024. View

15.

Hiani Y, Linsdell P . Functional Architecture of the Cytoplasmic Entrance to the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Pore. J Biol Chem. 2015; 290(25):15855-15865. PMC: 4505492. DOI: 10.1074/jbc.M115.656181. View

16.

Aartsma-Rus A, van Ommen G . Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications. RNA. 2007; 13(10):1609-24. PMC: 1986821. DOI: 10.1261/rna.653607. View

17.

Farinha C, Nogueira P, Mendes F, Penque D, Amaral M . The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70. Biochem J. 2002; 366(Pt 3):797-806. PMC: 1222832. DOI: 10.1042/BJ20011717. View

18.

Serohijos A, Hegedus T, Aleksandrov A, He L, Cui L, Dokholyan N . Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc Natl Acad Sci U S A. 2008; 105(9):3256-61. PMC: 2265173. DOI: 10.1073/pnas.0800254105. View

19.

Luz S, Cihil K, Brautigan D, Amaral M, Farinha C, Swiatecka-Urban A . LMTK2-mediated phosphorylation regulates CFTR endocytosis in human airway epithelial cells. J Biol Chem. 2014; 289(21):15080-93. PMC: 4031558. DOI: 10.1074/jbc.M114.563742. View

20.

Ghigo A, Murabito A, Sala V, Pisano A, Bertolini S, Gianotti A . A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases. Sci Transl Med. 2022; 14(638):eabl6328. PMC: 9869178. DOI: 10.1126/scitranslmed.abl6328. View